Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- Deel wants Rippling to hand over any agreements involving paying the alleged spy
- Uber eyes B2B logistics push in India through state-backed open commerce network
- VUZ gets $12M to scale immersive video experiences across emerging markets and the U.S.
- Crypto elite increasingly worried about their personal safety
- Grok says it’s ‘skeptical’ about Holocaust death toll, then blames ‘programming error’
- Heybike’s Alpha step-through e-bike is an affordable, all-terrain dreamboat
- U.S. lawmakers have concerns about Apple-Alibaba deal
- MIT disavows doctoral student paper on AI’s productivity benefits
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]